Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewCP 316819 is a selective glycogen phosphorylase inhibitor [IC50 values are 0.017 and 0.034 μM against human skeletal muscle glycogen phosphorylase a (huSMGPa) and liver glycogen phosphorylase a (huLGPa) respectively]. Antihyperglycemic agent.
CP 316819 is also offered as part of the Tocriscreen 2.0 Max. 了解 Tocris 化合物库的更多信息。
分子量 | 415.87 |
公式 | C21H22ClN3O4 |
储存 | Store at RT |
纯度 | ≥98% (HPLC) |
CAS Number | 186392-43-8 |
PubChem ID | 10273347 |
InChI Key | WEQLRDLTRCEUHG-PKOBYXMFSA-N |
Smiles | O=C(N[C@@H](CC3=CC=CC=C3)[C@H](C(N(OC)C)=O)O)C2=CC1=CC(Cl)=CC=C1N2 |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
溶剂 | 最高浓度 mg/mL | 最高浓度 mM | |
---|---|---|---|
溶解性 | |||
DMSO | 41.59 | 100 | |
ethanol | 41.59 | 100 |
以下数据基于产品分子量 415.87。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
浓度/溶剂体积/质量 | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.4 mL | 12.02 mL | 24.05 mL |
5 mM | 0.48 mL | 2.4 mL | 4.81 mL |
10 mM | 0.24 mL | 1.2 mL | 2.4 mL |
50 mM | 0.05 mL | 0.24 mL | 0.48 mL |
参考文献是支持产品生物活性的出版物。
Baker et al (2005) Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes 54 2453 PMID: 16046314
Freeman et al (2006) Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation site of the enzyme. Br.J.Pharmacol. 149 775 PMID: 17016495
Suh et al (2007) Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-ca J.Pharmacol.Exp.Ther. 321 45 PMID: 17251391
If you know of a relevant reference for CP 316819, please let us know.
关键词: CP 316819, CP 316819 supplier, glycogen, phosphorylase, inhibitors, inhibits, antihyperglycemic, antihyperglycaemic, transferases, carbohydrate, metabolism, CP316819, Phosphorylases, 3542, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。 CP 316819 的部分引用包括:
Jun et al (2021) Glycogen metabolism is dispensable for tumour progression in clear cell renal cell carcinoma. Nat Metab 3 327-336 PMID: 33758423
Galow et al (2014) Energy substrates that fuel fast neuronal network oscillations. J Exp Bot 8 398 PMID: 25538552
您是否知道使用了 Tocris CP 316819 的优秀论文? 请告知我们.
目前没有该产品的评论。 Be the first to review CP 316819 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image